Comprehensive polar metabolomics and lipidomics profiling discriminates the transformed from the non-transformed state in colon tissue and cell lines
暂无分享,去创建一个
[1] L. Vanhaecke,et al. Impact of storage conditions on the human stool metabolome and lipidome: Preserving the most accurate fingerprint. , 2020, Analytica chimica acta.
[2] Fan Wang,et al. Metabolomic Markers of Colorectal Tumor With Different Clinicopathological Features , 2020, bioRxiv.
[3] W. D. De Vos,et al. Validated comprehensive metabolomics and lipidomics analysis of colon tissue and cell lines. , 2019, Analytica chimica acta.
[4] S. Nishiumi,et al. GC/MS and LC/MS-based Tissue Metabolomic Analysis Detected Increased Levels of Antioxidant Metabolites in Colorectal Cancer. , 2019, The Kobe journal of medical sciences.
[5] Gabriela Kalna,et al. Improving the metabolic fidelity of cancer models with a physiological cell culture medium , 2019, Science Advances.
[6] L. Vanhaecke,et al. A validated multi-matrix platform for metabolomic fingerprinting of human urine, feces and plasma using ultra-high performance liquid-chromatography coupled to hybrid orbitrap high-resolution mass spectrometry. , 2018, Analytica chimica acta.
[7] P. Roca,et al. Non‐tumor adjacent tissue of advanced stage from CRC shows activated antioxidant response , 2018, Free radical biology & medicine.
[8] R. Nasr,et al. Ascorbic Acid in Colon Cancer: From the Basic to the Clinical Applications , 2018, International journal of molecular sciences.
[9] Yinglan Zhao,et al. LC‑MS/MS metabolome analysis detects the changes in the lipid metabolic profiles of dMMR and pMMR cells. , 2018, Oncology reports.
[10] Cyrille A M Krul,et al. Human lung epithelial cell cultures for analysis of inhaled toxicants: Lessons learned and future directions. , 2018, Toxicology in vitro : an international journal published in association with BIBRA.
[11] Nicholas S. Akins,et al. Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer , 2018, Current topics in medicinal chemistry.
[12] David S. Wishart,et al. HMDB 4.0: the human metabolome database for 2018 , 2017, Nucleic Acids Res..
[13] Lynn Vanhaecke,et al. Holistic Lipidomics of the Human Gut Phenotype Using Validated Ultra-High-Performance Liquid Chromatography Coupled to Hybrid Orbitrap Mass Spectrometry. , 2017, Analytical chemistry.
[14] Lin Chen,et al. Glutaminase sustains cell survival via the regulation of glycolysis and glutaminolysis in colorectal cancer. , 2017, Oncology letters.
[15] R. Lothe,et al. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies , 2017, Molecular Cancer.
[16] V. Ciminale,et al. Escaping Death: Mitochondrial Redox Homeostasis in Cancer Cells , 2017, Front. Oncol..
[17] J. Bornstein,et al. Colorectal Cancer Chemotherapy: The Evolution of Treatment and New Approaches. , 2017, Current medicinal chemistry.
[18] Hongchuan Jin,et al. Synthetic lethality of glutaminolysis inhibition, autophagy inactivation and asparagine depletion in colon cancer , 2017, Oncotarget.
[19] S. Sumner,et al. Metabolites as biomarkers of adverse reactions following vaccination: A pilot study using nuclear magnetic resonance metabolomics. , 2017, Vaccine.
[20] B. Melichar,et al. Correlation of lipidomic composition of cell lines and tissues of breast cancer patients using hydrophilic interaction liquid chromatography/electrospray ionization mass spectrometry and multivariate data analysis. , 2017, Rapid communications in mass spectrometry : RCM.
[21] W. D. De Vos,et al. Untargeted metabolomics of colonic digests reveals kynurenine pathway metabolites, dityrosine and 3-dehydroxycarnitine as red versus white meat discriminating metabolites , 2017, Scientific Reports.
[22] M. Priault,et al. mTORC1 inhibition in cancer cells protects from glutaminolysis-mediated apoptosis during nutrient limitation , 2017, Nature Communications.
[23] Elena Cerrada,et al. Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer , 2017, International journal of molecular sciences.
[24] S. Zalba,et al. Cell membrane modulation as adjuvant in cancer therapy. , 2017, Cancer treatment reviews.
[25] Feng Zhu,et al. Performance Evaluation and Online Realization of Data-driven Normalization Methods Used in LC/MS based Untargeted Metabolomics Analysis , 2016, Scientific Reports.
[26] C. Dang,et al. From Krebs to clinic: glutamine metabolism to cancer therapy , 2016, Nature Reviews Cancer.
[27] Ashutosh Kumar Singh,et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, The Lancet.
[28] Y. Chun,et al. Comparative metabolic and lipidomic profiling of human breast cancer cells with different metastatic potentials , 2016, Oncotarget.
[29] A. Erez,et al. A metabolic link between the urea cycle and cancer cell proliferation , 2016, Molecular & cellular oncology.
[30] W. D. De Vos,et al. Reducing Compounds Equivocally Influence Oxidation during Digestion of a High-Fat Beef Product, which Promotes Cytotoxicity in Colorectal Carcinoma Cell Lines. , 2016, Journal of agricultural and food chemistry.
[31] Lian‐Wen Qi,et al. Human plasma metabolomics for identifying differential metabolites and predicting molecular subtypes of breast cancer , 2016, Oncotarget.
[32] S. Böcker,et al. Searching molecular structure databases with tandem mass spectra using CSI:FingerID , 2015, Proceedings of the National Academy of Sciences.
[33] K. Tepp,et al. Metabolic remodeling in human colorectal cancer and surrounding tissues: alterations in regulation of mitochondrial respiration and metabolic fluxes , 2015, Biochemistry and biophysics reports.
[34] Daniel Golovko,et al. Colorectal cancer models for novel drug discovery , 2015, Expert opinion on drug discovery.
[35] M. Graham,et al. The multifactorial role of the 3Rs in shifting the harm-benefit analysis in animal models of disease , 2015, European journal of pharmacology.
[36] M. Cekanova,et al. Animal models and therapeutic molecular targets of cancer: utility and limitations , 2014, Drug design, development and therapy.
[37] Liam O'Connor,et al. Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer. , 2014, Cancer research.
[38] J. McGowan,et al. Intravenous Vitamin C and Cancer , 2014, Integrative cancer therapies.
[39] E. Bowman,et al. Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans. , 2014, Gastroenterology.
[40] G. Singh. Mitochondrial FAD-linked Glycerol-3-phosphate Dehydrogenase: A Target for Cancer Therapeutics , 2014, Pharmaceuticals.
[41] R. Lothe,et al. Epigenetic and genetic features of 24 colon cancer cell lines , 2013, Oncogenesis.
[42] G. Meijer,et al. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications. , 2013, Clinical biochemistry.
[43] J. Fleet,et al. Animal models of colorectal cancer , 2013, Cancer and Metastasis Reviews.
[44] J. Azuma,et al. Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production , 2012, Amino Acids.
[45] Yair Lotan,et al. Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression. , 2011, Cancer research.
[46] T. Bathen,et al. Magnetic resonance metabolomics of intact tissue: a biotechnological tool in cancer diagnostics and treatment evaluation. , 2010, Cancer research.
[47] David S. Wishart,et al. MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data , 2010, Nucleic Acids Res..
[48] M. Brázdová,et al. Fetal colon cell line FHC exhibits tumorigenic phenotype, complex karyotype, and TP53 gene mutation. , 2010, Cancer genetics and cytogenetics.
[49] M. Tomita,et al. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. , 2009, Cancer research.
[50] V. Detours,et al. Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells? , 2009, Biochimica et biophysica acta.
[51] Charles Giardina,et al. Mouse models for the study of colon carcinogenesis. , 2008, Carcinogenesis.
[52] Nigel W. Hardy,et al. Proposed minimum reporting standards for chemical analysis , 2007, Metabolomics.
[53] Eoin Fahy,et al. LIPID MAPS online tools for lipid research , 2007, Nucleic Acids Res..
[54] D. Chopra,et al. Primary and long term epithelial cell cultures from human fetal normal colonic mucosa , 1984, In Vitro.
[55] P. Arnstein,et al. Source, alterations, characteristics and use of a new dog cell line (Cf2Th) , 1976, In Vitro.
[56] R. Shoemaker. The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.
[57] Stefan Schneeberger,et al. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[58] H. Daniel,et al. Increased carnitine-dependent fatty acid uptake into mitochondria of human colon cancer cells induces apoptosis. , 2005, The Journal of nutrition.
[59] G. Prendergast,et al. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy , 2005, Nature Medicine.
[60] I. Kola,et al. Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.
[61] E. Jacobson,et al. Mapping the role of NAD metabolism inprevention and treatment of carcinogenesis , 2004, Molecular and Cellular Biochemistry.
[62] B. Marian. In vitro models for the identification and characterization of tumor-promoting and protective factors for colon carcinogenesis. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[63] R. Hay,et al. Isolation and culture of colonic epithelial cells in serum-free medium , 1985 .
[64] Thomas D. Schmittgen,et al. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .